(Q73998265)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11398885%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

title

Activity of the dolastatin analogue, LU103793, in malignant melanoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11398885%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

author name string

J Smyth

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11398885%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

M E Boneterre

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11398885%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

J Schellens

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11398885%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

H Calvert

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11398885%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

G Greim

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11398885%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

J Wanders

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11398885%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

A Hanauske

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11398885%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

EORTC Early Clinical Studies Group

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11398885%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

publication date

1 April 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11398885%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11398885%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11398885%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

509-511

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11398885%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11398885%20AND%20SRC:MED&resulttype=core&format=json

Marine Animal Biosynthetic Constituents For Cancer Chemotherapy

8 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011194910571

7 January 2021

The isolation and structure of a remarkable marine animal antineoplastic constituent: dolastatin 10

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011194910571

7 January 2021

Dolastatin 10, a powerful cytostatic peptide derived from a marine animal. Inhibition of tubulin polymerization mediated through the vinca alkaloid binding domain

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011194910571

7 January 2021

Dolastatin 15, a potent antimitotic depsipeptide derived from Dolabella auricularia. Interaction with tubulin and effects of cellular microtubules

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011194910571

7 January 2021

Phase I and pharmacokinetic study of the water-soluble dolastatin 15 analog LU103793 in patients with advanced solid malignancies

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011194910571

7 January 2021

Identifiers

DOI

10.1023/A:1011194910571

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11398885%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference